<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39065072</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>27</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>DNA Methylation Levels of the ACE2 Promoter Are Not Associated with Post-COVID-19 Symptoms in Individuals Who Had Been Hospitalized Due to COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1304</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms12071304</ELocationID><Abstract><AbstractText>It is known that SARS-CoV-2 can translocate via membrane ACE2 exopeptidase into the host cells, and thus hypomethylation of ACE2 possibly upregulates its expression, enhancing the risk of SARS-CoV-2 infection. This study investigated if DNA methylation levels of the ACE2 promoter are associated with the development of post-COVID-19 symptomatology in a cohort of COVID-19 survivors who had been previously hospitalized. Non-stimulated saliva samples were obtained from 279 (51.5 male, mean age: 56.5 &#xb1; 13.0 years old) COVID-19 survivors who were hospitalized during the first wave of the pandemic. A face-to-face interview in which patients described the presence of post-COVID-19 symptoms (defined as a symptom that started no later than three months after SARS-CoV-2 infection) that they suffered from to an experienced healthcare trainer was conducted. Methylation of five CpG dinucleotides in the ACE2 promoter was quantified using bisulfite pyrosequencing. The percentage of methylation (%) was associated with the presence of the following reported post-COVID-19 symptoms: fatigue, dyspnea at rest, dyspnea at exertion, brain fog, memory loss, concentration loss, or gastrointestinal problems. Participants were assessed a mean of 17.8 (SD: 5.3) months after hospitalization. At that time, 88.1% of the patients experienced at least one post-COVID-19 symptom (mean number for each patient: 3.0; SD: 1.9 post-COVID-19 symptoms). Dyspnea at exertion (67.3%), fatigue (62.3%), and memory loss (31.2%) were the most frequent post-COVID-19 symptoms in the sample. Overall, the analysis did not reveal any difference in the methylation of the ACE2 promoter in any of the CpG locations according to the presence or absence of fatigue, dyspnea at rest, dyspnea at exertion, memory loss, brain fog, concentration loss, and gastrointestinal problems. This study did not find an association between methylation of ACE2 promoter and the presence of post-COVID-19 fatigue, dyspnea, cognitive or gastrointestinal problems in previously hospitalized COVID-19 survivors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), Sensory Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az-Gil</LastName><ForeName>Gema</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3480-1490</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-Crujera</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1022-5831</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-S&#xe1;nchez</LastName><ForeName>Stella M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-7140-4286</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambite-Quesada</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6755-8189</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Macho</LastName><ForeName>Juan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8860-6837</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan-Murua</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4212-7419</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco-Moreno</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellicer-Valero</LastName><ForeName>Oscar J</ForeName><Initials>OJ</Initials><Identifier Source="ORCID">0000-0002-0104-1029</Identifier><AffiliationInfo><Affiliation>Image Processing Laboratory (IPL), Universitat de Val&#xe8;ncia, Parc Cient&#xed;fic, 46980 Paterna, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arendt-Nielsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), Sensory Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology &amp; Hepatology, Mech-Sense, Aalborg University Hospital, DK 9100 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Steno Diabetes Center North Denmark, Clinical Institute, Aalborg University Hospital, DK 9100 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1331-129X</Identifier><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), Sensory Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial Surgery, Aalborg University Hospital, DK 9100 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>LONG-COVID-EXP-CM</GrantID><Agency>Comunidad de Madrid</Agency><Country/></Grant><Grant><GrantID>NNF21OC0067235</GrantID><Agency>Novo Nordisk Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">methylation</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39065072</ArticleId><ArticleId IdType="pmc">PMC11279155</ArticleId><ArticleId IdType="doi">10.3390/microorganisms12071304</ArticleId><ArticleId IdType="pii">microorganisms12071304</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Deans C., Maggert K.A. What do you mean, &#x201c;epigenetic&#x201d;? Genetics. 2015;199:887&#x2013;896. doi: 10.1534/genetics.114.173492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.114.173492</ArticleId><ArticleId IdType="pmc">PMC4391566</ArticleId><ArticleId IdType="pubmed">25855649</ArticleId></ArticleIdList></Reference><Reference><Citation>Capp J.P. Interplay between genetic, epigenetic, and gene expression variability: Considering complexity in evolvability. Evol. Appl. 2021;14:893&#x2013;901. doi: 10.1111/eva.13204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eva.13204</ArticleId><ArticleId IdType="pmc">PMC8061278</ArticleId><ArticleId IdType="pubmed">33897810</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Netea M.G. Trained innate immunity, epigenetics, and COVID-19. N. Engl. J. Med. 2020;383:1078&#x2013;1080. doi: 10.1056/NEJMcibr2011679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2011679</ArticleId><ArticleId IdType="pubmed">32905684</ArticleId></ArticleIdList></Reference><Reference><Citation>Behura A., Naik L., Patel S., Das M., Kumar A., Mishra A., Nayak D.K., Manna D., Mishra A., Dhiman R. Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection. Biochim. Biophys. Acta Mol. Basis Dis. 2023;1869:166634. doi: 10.1016/j.bbadis.2022.166634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2022.166634</ArticleId><ArticleId IdType="pmc">PMC9790847</ArticleId><ArticleId IdType="pubmed">36577469</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore L.D., Le T., Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38:23&#x2013;38. doi: 10.1038/npp.2012.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2012.112</ArticleId><ArticleId IdType="pmc">PMC3521964</ArticleId><ArticleId IdType="pubmed">22781841</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey A., Vaishak K., Deka D., Radhakrishnan A.K., Paul S., Shanmugam P., Daniel A.P., Pathak S., Duttaroy A.K., Banerjee A. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: An updated review. Infection. 2023;51:1603&#x2013;1618. doi: 10.1007/s15010-023-02017-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02017-8</ArticleId><ArticleId IdType="pmc">PMC10008189</ArticleId><ArticleId IdType="pubmed">36906872</ArticleId></ArticleIdList></Reference><Reference><Citation>Balnis J., Madrid A., Hogan K.J., Drake L.A., Chieng H.C., Tiwari A., Vincent C.E., Chopra A., Vincent P.A., Robek M.D., et al. Blood DNA Methylation and COVID-19 outcomes. Clin. Epigenet. 2021;13:118. doi: 10.1186/s13148-021-01102-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-021-01102-9</ArticleId><ArticleId IdType="pmc">PMC8148415</ArticleId><ArticleId IdType="pubmed">34034806</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh H.O., Choudhari R., Nema V., Khan A.A. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease. Microb. Pathog. 2021;150:104621. doi: 10.1016/j.micpath.2020.104621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2020.104621</ArticleId><ArticleId IdType="pmc">PMC7709597</ArticleId><ArticleId IdType="pubmed">33278516</ArticleId></ArticleIdList></Reference><Reference><Citation>Faramarzi A., Safaralizadeh R., Dastmalchi N., Teimourian S. Epigenetic-related effects of COVID-19 on human cells. Infect. Disord. Drug Targets. 2022;22:21&#x2013;26. doi: 10.2174/1871526522666220420093029.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871526522666220420093029</ArticleId><ArticleId IdType="pubmed">35450534</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafipour R., Mohammadi D., Momeni M., Moghbelinejad S. ACE-2 Expression and methylation pattern in bronchoalveolar lavage fluid and bloods of Iranian ARDS COVID-19 patients. Int. J. Mol. Cell Med. 2022;11:55&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9653551</ArticleId><ArticleId IdType="pubmed">36397811</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel G., Paola A.R., Nancy G., Fernando S.O., Beatriz A., Zulema R., Julieth A., Claudia C., Adriana R. Epigenetic mechanisms and host factors impact ACE2 gene expression: Implications in COVID-19 susceptibility. Infect. Genet. Evol. 2022;104:105357. doi: 10.1016/j.meegid.2022.105357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2022.105357</ArticleId><ArticleId IdType="pmc">PMC9420046</ArticleId><ArticleId IdType="pubmed">36038007</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes L.D., Ingram J., Sculthorpe N.F. More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A scoping review. Front. Med. 2021;8:750378. doi: 10.3389/fmed.2021.750378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.750378</ArticleId><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Wulf Hanson S., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Notarte K.I., Macasaet R., Velasco J.V., Catahay J.A., Therese Ver A., Chung W., Valera-Calero J.A., Navarro-Santana M. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis. J. Infect. 2024;88:77&#x2013;88. doi: 10.1016/j.jinf.2023.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.12.004</ArticleId><ArticleId IdType="pubmed">38101521</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Raveendran A.V., Giordano R., Arendt-Nielsen L. Long COVID or post-COVID-19 condition: Past, present and future research directions. Microorganisms. 2023;11:2959. doi: 10.3390/microorganisms11122959.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11122959</ArticleId><ArticleId IdType="pmc">PMC10745830</ArticleId><ArticleId IdType="pubmed">38138102</ArticleId></ArticleIdList></Reference><Reference><Citation>Balnis J., Madrid A., Hogan K.J., Drake L.A., Adhikari A., Vancavage R., Singer H.A., Alisch R.S., Jaitovich A. Whole-Genome methylation sequencing reveals that COVID-19-induced epigenetic dysregulation remains 1 year after hospital discharge. Am. J. Respir. Cell Mol. Biol. 2023;68:594&#x2013;597. doi: 10.1165/rcmb.2022-0433LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2022-0433LE</ArticleId><ArticleId IdType="pmc">PMC10174161</ArticleId><ArticleId IdType="pubmed">37125894</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikesj&#xf6; F., Sayyab S., Karlsson L., Apostolou E., Ros&#xe9;n A., Hedman K., Lerm M. Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells. Clin. Epigenet. 2022;14:172. doi: 10.1186/s13148-022-01398-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01398-1</ArticleId><ArticleId IdType="pmc">PMC9748378</ArticleId><ArticleId IdType="pubmed">36517875</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikeska T., Felsberg J., Hewitt C.A., Dobrovic A. Analysing DNA methylation using bisulphite pyrosequencing. Methods Mol. Biol. 2011;791:33&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">21913070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan R., Mao S.Q., Gu T.L., Zhong F.D., Gong M.L., Hao L.M., Yin F.Y., Dong C.Z., Zhang L.N. Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension. Mol. Med. Rep. 2017;15:3905&#x2013;3911. doi: 10.3892/mmr.2017.6460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6460</ArticleId><ArticleId IdType="pubmed">28440441</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Notarte K.I., Peligro P.J., Velasco J.V., Ocampo M.J., Henry B.M., Arendt-Nielsen L., Torres-Macho J., Plaza-Manzano G. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: A systematic review of the literature. Viruses. 2022;14:2629. doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M., Ma Y., Deng J., Liu M., Liu J. Comparison of long COVID-19 caused by different SARS-CoV-2 strains: A systematic review and meta-analysis. Int. J. Environ. Res. Public Health. 2022;19:16010. doi: 10.3390/ijerph192316010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan N., Lv Z.H., Sun C.R., Wen Y.Y., Tao T.Y., Qian D., Tao F.P., Yu J.H. Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Front. Public Health. 2023;11:1112383. doi: 10.3389/fpubh.2023.1112383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1112383</ArticleId><ArticleId IdType="pmc">PMC9978404</ArticleId><ArticleId IdType="pubmed">36875356</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;ller Johansen L., Gerra M.C., Arendt-Nielsen L. Time course of DNA methylation in pain conditions: From experimental models to humans. Eur. J. Pain. 2021;25:296&#x2013;312. doi: 10.1002/ejp.1674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1674</ArticleId><ArticleId IdType="pubmed">33063322</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajerian M., Alvarado S., Millecamps M., Vachon P., Crosby C., Bushnell M.C., Szyf M., Stone L.S. Peripheral nerve injury is associated with chronic, reversible changes in global DNA methylation in the mouse prefrontal cortex. PLoS ONE. 2013;8:e55259. doi: 10.1371/journal.pone.0055259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055259</ArticleId><ArticleId IdType="pmc">PMC3557255</ArticleId><ArticleId IdType="pubmed">23383129</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>